Pharmaceutical Technology November 25, 2022
GlobalData Healthcare

Many healthcare companies are expected to prioritise AI as their main investment target over the next two years.

Artificial intelligence (AI) was seen as one of the top current investment priorities and was thought to continue to attract investment in the healthcare sector in the upcoming two years, according to GlobalData’s latest report ‘Digital Transformation and Emerging Technology in the Healthcare Industry – 2022 Edition’.

In this survey-based report tracker, digital media was prioritised as a top current investment target, with 53% of surveyed respondents confirming that their companies are currently investing in this technology. It was followed by AI, social media and big data (Figure 1). Compared with last year’s data, digital media saw...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Survey / Study, Technology, Trends
‘Think about the hype’ - AI holds disruptive potential for health care
Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA
Investigators Train AI Systems to Predict RA Outcomes
Confronting the Digital Dilemma in Healthcare’s Quest for Innovation
NIH develops AI tool to better pair cancer patients with drugs

Share This Article